-
Publication Venue For
-
Asts-Ast Report Of Fda Meeting On Regulatory Expectations For Xenotransplantation Products.
2023
-
Transplanting hepatitis B surface antigen-positive livers in the United States: outcomes and opportunities.
2023
-
Epidemiology, Management, and Clinical Outcomes of Extrapulmonary Mycobacterium abscessus Complex Infections in Heart Transplant and Ventricular Assist Device Recipients.
2023
-
Xenorecognition and costimulation of porcine endothelium-derived extracellular vesicles in initiating human porcine-specific T cell immune responses.
2023
-
Psychosocial fitness for transplant: factors yet unmeasured.
2023
-
A comparison of deprivation indices and application to transplant populations..
23:377-386.
2023
-
Addressing sex-based disparities in solid organ transplantation in the United States - a conference report..
23:316-325.
2023
-
American Society of Transplant Surgeons recommendations on best practices in donation after circulatory death organ procurement..
23:171-179.
2023
-
OPTN/SRTR 2021 Annual Data Report: Vascularized Composite Allograft..
23:S523-S545.
2023
-
Clinical recommendations for posttransplant assessment of anti-HLA (Human Leukocyte Antigen) donor-specific antibodies: A Sensitization in Transplantation: Assessment of Risk consensus document..
23:115-132.
2023
-
Information design to support growth, quality, and equity of the US transplant system..
23:5-10.
2023
-
A consensus conference to define the utility of advanced infectious disease diagnostics in solid organ transplant recipients..
22:3150-3169.
2022
-
Addition of interleukin-6 receptor blockade to carfilzomib-based desensitization in a highly sensitized nonhuman primate model..
22 Suppl 4:1-11.
2022
-
Epidemiology of surgical site infections after solid organ transplants in the period 2015-2019: A single-center retrospective cohort study..
22:3021-3030.
2022
-
Prognostic implications of and clinical risk factors for acute lung injury and organizing pneumonia after lung transplantation: Data from a multicenter prospective cohort study..
22:3002-3011.
2022
-
Social determinants of health data in solid organ transplantation: National data sources and future directions..
22:2293-2301.
2022
-
Plasma CXCL9 and CXCL10 at allograft injury predict chronic lung allograft dysfunction..
22:2169-2179.
2022
-
Apples to apples: The challenges of studying COVID-19 mortality in solid organ transplant recipients..
22:1929-1930.
2022
-
Letter to the editor in response to: Measuring success in pig to non-human-primate renal xenotransplantation: Systematic review and comparative outcomes analysis of 1051 life sustaining NHP renal allo- and xeno-transplants by Firl and Markmann..
22:1933-1934.
2022
-
IFI16-STING-NF-κB signaling controls exogenous mitochondrion-induced endothelial activation..
22:1578-1592.
2022
-
When pigs fly..
22:1007-1008.
2022
-
HOPE in action: A prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV..
22:853-864.
2022
-
OPTN/SRTR 2020 Annual Data Report: VCA..
22 Suppl 2:623-647.
2022
-
Lung transplantation after ex vivo lung perfusion versus static cold storage: An institutional cost analysis..
22:552-564.
2022
-
Antibodies, boosters, and optimizing SARS-CoV-2 vaccines for transplantation: A call for more research..
22:24-27.
2022
-
Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic..
22:279-288.
2022
-
Buyer beware: The risks of donor-derived vaccine-induced thrombosis and thrombocytopenia..
21:3829-3830.
2021
-
Correlation between BAL CXCR3 chemokines and lung allograft histopathologies: A multicenter study..
21:3401-3410.
2021
-
Age-related effects on thymic output and homeostatic T cell expansion following depletional induction in renal transplant recipients..
21:3163-3174.
2021
-
Tenosynovitis in a renal transplant recipient: Making the diagnosis firsthand..
21:3196-3198.
2021
-
COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study..
21:2774-2784.
2021
-
The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy..
21:2637-2645.
2021
-
Dismantling structural racism as a root cause of racial disparities in COVID-19 and transplantation..
21:2327-2332.
2021
-
Need for improvements in simultaneous heart-kidney allocation: The limitation of pretransplant glomerular filtration rate..
21:2468-2478.
2021
-
Regulatory updates are needed to prevent the commercialization of islet transplantation in the United States..
21:2620-2622.
2021
-
Bacteremia in solid organ transplant recipients as compared to immunocompetent patients: Acute phase cytokines and outcomes in a prospective, matched cohort study..
21:2113-2122.
2021
-
Eudaimonia: An Aristotelian approach to transplantation..
21:2014-2017.
2021
-
Expanding donor availability in lung transplantation: A case report of 5000 miles traveled..
21:2269-2272.
2021
-
Frailty and aging-associated syndromes in lung transplant candidates and recipients..
21:2018-2024.
2021
-
Transplant social worker and donor financial assistance to increase living donor kidney transplants among African Americans: The TALKS Study, a randomized comparative effectiveness trial..
21:2175-2187.
2021
-
A prospective multicenter pilot study of HIV-positive deceased donor to HIV-positive recipient kidney transplantation: HOPE in action..
21:1754-1764.
2021
-
C4 article: Implications of COVID-19 in transplantation..
21:1801-1815.
2021
-
Cryptococcus transmission through solid organ transplantation in the United States: A report from the Ad Hoc Disease Transmission Advisory Committee..
21:1911-1923.
2021
-
Optimization of de novo belatacept-based immunosuppression administered to renal transplant recipients..
21:1691-1698.
2021
-
Delayed graft function and acute rejection following HLA-incompatible living donor kidney transplantation..
21:1612-1621.
2021
-
Phase 3 trial of human islet-after-kidney transplantation in type 1 diabetes..
21:1477-1492.
2021
-
A three-tier system for evaluation of organ procurement organizations' willingness to pursue and utilize nonideal donor lungs..
21:1269-1277.
2021
-
Acute murine cytomegalovirus disrupts established transplantation tolerance and causes recipient allo-sensitization..
21:515-524.
2021
-
Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement..
21:475-483.
2021
-
Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement..
21:460-474.
2021
-
Primary graft dysfunction and health-related quality of life after transplantation: The good, the bad, and the missing..
21:456-457.
2021
-
Relationship between antithymocyte globulin, T cell phenotypes, and clinical outcomes in pediatric kidney transplantation..
21:766-775.
2021
-
Ten years of donor-derived disease: A report of the disease transmission advisory committee..
21:689-702.
2021
-
Role of low-dose calcineurin inhibitor regimens in pediatric kidney transplantation..
21:11-12.
2021
-
Understanding the impact of HLA molecular mismatch in solid organ transplantation: Are we there yet?.
21:9-10.
2021
-
Vascularized composite allotransplantation in the United States: A retrospective analysis of the Organ Procurement and Transplantation Network data after 5 years of the Final Rule..
21:291-296.
2021
-
Introducing a novel experimental model of bladder transplantation in mice..
20:3558-3566.
2020
-
Kidney transplantation using alemtuzumab, belatacept, and sirolimus: Five-year follow-up..
20:3609-3619.
2020
-
Kidney transplant in the COVID era: Cautious optimism and continued vigilance..
20:2971-2972.
2020
-
Lung transplantation during the COVID-19 pandemic: Safely navigating the new "normal"..
20:3094-3105.
2020
-
Donor apoptotic cell-based therapy for effective inhibition of donor-specific memory T and B cells to promote long-term allograft survival in allosensitized recipients..
20:2728-2739.
2020
-
Pharmacological approaches to antibody-mediated rejection-Are we getting closer?.
20:2637-2638.
2020
-
Rejection in the setting of non-HLA antibody: New tools for navigating bench to bedside..
20:2639-2641.
2020
-
Sensitization in transplantation: Assessment of risk (STAR) 2019 Working Group Meeting Report..
20:2652-2668.
2020
-
Transplantation, Bioengineering, and Regeneration of the Endocrine Pancreas Eds: Giuseppe Orlando, Lorenzo Piemonti, Camillo Ricordi, Robert J. Stratta Rainer W.G. Gruessner Cambridge, MA: Academic Press, 2020; Vol. 1, 865 pages, Vol. 2, 546 pages.
2020
-
Banff Digital Pathology Working Group: Going digital in transplant pathology..
20:2392-2399.
2020
-
Donor evaluation in the era of HIV-positive organ transplantation: The importance of the infectious diseases specialist..
20:2589-2592.
2020
-
Dialysis facility referral and start of evaluation for kidney transplantation among patients treated with dialysis in the Southeastern United States..
20:2113-2125.
2020
-
Coronavirus disease 2019: Implications of emerging infections for transplantation..
20:1768-1772.
2020
-
Antibody-Mediated Rejection..
20 Suppl 4:1.
2020
-
Ensuring long-term equity after pediatric liver transplantation..
20:1480-1481.
2020
-
Experimental modeling of desensitization: What have we learned about preventing AMR?.
20 Suppl 4:2-11.
2020
-
Highlights from the clinical trials in organ transplantation (CTOT)-20 and CTOT-22 Consortium studies in lung transplant..
20:1489-1494.
2020
-
Rejection of xenogeneic porcine islets in humanized mice is characterized by graft-infiltrating Th17 cells and activated B cells..
20:1538-1550.
2020
-
Hand transplantation in the United States: A review of the Organ Procurement and Transplantation Network/United Network for Organ Sharing Database..
20:1417-1423.
2020
-
The best transplant strategy? It depends..
20:1221-1222.
2020
-
Demystifying "bad luck": Seemingly unrelated risk factors for CLAD may be connected by a common pathway..
20:920-921.
2020
-
Amphiregulin contributes to airway remodeling in chronic allograft dysfunction after lung transplantation..
20:825-833.
2020
-
B cell reconstitution following alemtuzumab induction under a belatacept-based maintenance regimen..
20:653-662.
2020
-
Correlation of preoperative imaging characteristics with donor outcomes and operative difficulty in laparoscopic donor nephrectomy..
20:752-760.
2020
-
Fatal hepatic necrosis after nivolumab as a bridge to liver transplant for HCC: Are checkpoint inhibitors safe for the pretransplant patient?.
20:879-883.
2020
-
Tailored use of belatacept in adolescent kidney transplantation..
20:884-888.
2020
-
IgG4 donor-specific HLA antibody profile is associated with subclinical rejection in stable pediatric liver recipients..
20:513-524.
2020
-
Liver transplantation for hepatocellular carcinoma: Management after the transplant..
20:333-347.
2020
-
Long-term outcomes in patients with obesity and renal disease after sleeve gastrectomy..
20:422-429.
2020
-
The impact of belatacept on third-party HLA alloantibodies in highly sensitized kidney transplant recipients..
20:573-581.
2020
-
Liver transplant for hepatocellular carcinoma in the United States: Evolving trends over the last three decades..
20:220-230.
2020
-
Confounding Virus in Mouse Facilities..
19:3217.
2019
-
A nonlinear relationship between visceral adipose tissue and frailty in adult lung transplant candidates..
19:3155-3161.
2019
-
CD68/CD31 immunohistochemistry double stain demonstrates increased accuracy in diagnosing pathologic antibody-mediated rejection in cardiac transplant patients..
19:3149-3154.
2019
-
Secondary lymphoid tissue and costimulation-blockade resistant rejection: A nonhuman primate renal transplant study..
19:2350-2357.
2019
-
Agree on much, except it is time for change..
19:1912-1916.
2019
-
Beyond death and graft survival-Variation in outcomes after liver transplant. Results from the NSQIP transplant beta phase..
19:2108-2115.
2019
-
Circulating mitochondria in organ donors promote allograft rejection..
19:1917-1929.
2019
-
Frailty in liver transplantation: An expert opinion statement from the American Society of Transplantation Liver and Intestinal Community of Practice..
19:1896-1906.
2019
-
Small bowel and abdominal wall transplantation: A novel technique for synchronous revascularization..
19:2122-2126.
2019
-
Variables of importance in the Scientific Registry of Transplant Recipients database predictive of heart transplant waitlist mortality..
19:2067-2076.
2019
-
Parenteral administration of oral medications in lung transplant recipients: An underrecognized problem..
19:1552-1559.
2019
-
FDA jeopardizes the lives of lung transplant recipients and in the process severely increases the cost to develop new immunosuppression..
19:971-972.
2019
-
Dual targeting: Combining costimulation blockade and bortezomib to permit kidney transplantation in sensitized recipients..
19:724-736.
2019
-
Lymphocyte depletion and risk of acute rejection in renal transplant recipients at increased risk for delayed graft function..
19:781-789.
2019
-
Receptor tyrosine kinase MerTK suppresses an allogenic type I IFN response to promote transplant tolerance..
19:674-685.
2019
-
The importance of drug safety and tolerability in the development of new immunosuppressive therapy for transplant recipients: The Transplant Therapeutics Consortium's position statement..
19:625-632.
2019
-
Vascularized composite allotransplantation in the United States: A descriptive analysis of the Organ Procurement and Transplantation Network Data..
19:865-875.
2019
-
Limited health literacy and adverse outcomes among kidney transplant candidates..
19:457-465.
2019
-
C4: An experiment in academic dialogue..
18:2619.
2018
-
Current opinions in organ allocation..
18:2625-2634.
2018
-
Maximizing utilization of the donor pool by appropriate classification of hepatitis C antibody-positive donors..
18:2380-2381.
2018
-
Another piece of the antibody puzzle: Observations from the HALT study..
18:2111-2112.
2018
-
Meeting report of the STAR-Sensitization in Transplantation Assessment of Risk: Naïve Abdominal Transplant Organ subgroup focus on kidney transplantation..
18:2120-2134.
2018
-
De novo belatacept in clinical vascularized composite allotransplantation..
18:1804-1809.
2018
-
Sensitization in Transplantation: Assessment of Risk (STAR) 2017 Working Group Meeting Report..
18:1604-1614.
2018
-
Primary graft dysfunction after heart transplantation: Incidence, trends, and associated risk factors..
18:1461-1470.
2018
-
Aquaporin 4 blockade improves survival of murine heart allografts subjected to prolonged cold ischemia..
18:1238-1246.
2018
-
Early barriers to neonatal porcine islet engraftment in a dual transplant model..
18:998-1006.
2018
-
Hospital readmissions following HLA-incompatible live donor kidney transplantation: A multi-center study..
18:650-658.
2018
-
IL-7 receptor heterogeneity as a mechanism for repertoire change during postdepletional homeostatic proliferation and its relation to costimulation blockade-resistant rejection..
18:720-730.
2018
-
Postoperative cognitive dysfunction and mortality following lung transplantation..
18:696-703.
2018
-
Laparoscopic sleeve gastrectomy improves renal transplant candidacy and posttransplant outcomes in morbidly obese patients..
18:410-416.
2018
-
Getting to transplantation..
18:7-8.
2018
-
The outstanding questions in transplantation: It's about time…..
18:271-272.
2018
-
Living donor follow-up: Unfunded mandates and the Hippocratic oath where perfect may be the enemy of good?.
17:3006-3007.
2017
-
The Incremental Cost of Incompatible Living Donor Kidney Transplantation: A National Cohort Analysis..
17:3123-3130.
2017
-
Belatacept Combined With Transient Calcineurin Inhibitor Therapy Prevents Rejection and Promotes Improved Long-Term Renal Allograft Function..
17:2922-2936.
2017
-
Donor-derived hepatitis C transmission from NAT negative donors-Still an unexpected event!.
17:2989.
2017
-
Erratum..
17:2993.
2017
-
Prevention and Control of Seasonal Influenza With Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2017-18 Influenza Season..
17:2970-2982.
2017
-
Report From the American Society of Transplantation Conference on Donor Heart Selection in Adult Cardiac Transplantation in the United States..
17:2559-2566.
2017
-
Depletion-Resistant CD4 T Cells Enhance Thymopoiesis During Lymphopenia..
17:2008-2019.
2017
-
Thrombalexin: Use of a Cytotopic Anticoagulant to Reduce Thrombotic Microangiopathy in a Highly Sensitized Model of Kidney Transplantation..
17:2055-2064.
2017
-
Novel Magnetic Resonance Imaging for Assessment of Bronchial Stenosis in Lung Transplant Recipients..
17:1895-1904.
2017
-
Relationship Among Viremia/Viral Infection, Alloimmunity, and Nutritional Parameters in the First Year After Pediatric Kidney Transplantation..
17:1549-1562.
2017
-
Selective Targeting of High-Affinity LFA-1 Does Not Augment Costimulation Blockade in a Nonhuman Primate Renal Transplantation Model..
17:1193-1203.
2017
-
Changes in Urinary Microbiome Populations Correlate in Kidney Transplants With Interstitial Fibrosis and Tubular Atrophy Documented in Early Surveillance Biopsies..
17:712-723.
2017
-
The Knife's Edge of Tolerance: Inducing Stable Multilineage Mixed Chimerism but With a Significant Risk of CMV Reactivation and Disease in Rhesus Macaques..
17:657-670.
2017
-
Painful Groin Mass in a Liver Transplant Recipient..
17:573-575.
2017
-
Hemorrhagic Herpes Simplex Virus Type 1 Nephritis: An Unusual Cause of Acute Allograft Dysfunction..
17:287-291.
2017
-
Lung Transplant Center Volume Ameliorates Adverse Influence of Prolonged Ischemic Time on Mortality..
17:218-226.
2017
-
Coccidioidomycosis Transmission Through Organ Transplantation: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee..
16:3562-3567.
2016
-
DAMP-Induced Allograft and Tumor Rejection: The Circle Is Closing..
16:3322-3337.
2016
-
Plasma-Derived C1 Esterase Inhibitor for Acute Antibody-Mediated Rejection Following Kidney Transplantation: Results of a Randomized Double-Blind Placebo-Controlled Pilot Study..
16:3468-3478.
2016
-
Expanding the Donor Pool With Normothermic Ex Vivo Liver Perfusion: The Future Is Now..
16:3075-3076.
2016
-
Staging of Bilateral Lung Transplantation for High-Risk Patients With Interstitial Lung Disease: One Lung at a Time..
16:3270-3277.
2016
-
Steroid-Responsive Acute Rejection Should Not Be the End Point for Immunosuppressive Trials..
16:3077-3078.
2016
-
2016 Comprehensive Update of the Banff Working Group on Liver Allograft Pathology: Introduction of Antibody-Mediated Rejection..
16:2816-2835.
2016
-
Splenic Irradiation for the Treatment of Severe Antibody-Mediated Rejection..
16:3041-3045.
2016
-
Introducing the Wiley Transplant Peer Review Network..
16:2505-2507.
2016
-
Rapamycin Interferes With Postdepletion Regulatory T Cell Homeostasis and Enhances DSA Formation Corrected by CTLA4-Ig..
16:2612-2623.
2016
-
Response to "Does Sleep Play a Role in the Relationship Among Depression, Anxiety, and Mortality in Lung Transplanted Patients?"..
16:2495.
2016
-
Regulating T Cell Behavior..
16:1949-1950.
2016
-
Antibody-Mediated Rejection in Sensitized Nonhuman Primates: Modeling Human Biology..
16:1726-1738.
2016
-
The OPTN Deceased Donor Potential Study: Implications for Policy and Practice..
16:1707-1714.
2016
-
Anti-Leukocyte Function-Associated Antigen 1 Therapy in a Nonhuman Primate Renal Transplant Model of Costimulation Blockade-Resistant Rejection..
16:1456-1464.
2016
-
CD57(+) CD4 T Cells Underlie Belatacept-Resistant Allograft Rejection..
16:1102-1112.
2016
-
Protein Quantitative Trait Loci Analysis Identifies Genetic Variation in the Innate Immune Regulator TOLLIP in Post-Lung Transplant Primary Graft Dysfunction Risk..
16:833-840.
2016
-
Postdepletion Lymphocyte Reconstitution During Belatacept and Rapamycin Treatment in Kidney Transplant Recipients..
16:550-564.
2016
-
The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome..
16:640-649.
2016
-
One Size Does Not Fit All--Regional Variation in the Impact of the Share 35 Liver Allocation Policy..
16:137-142.
2016
-
Psychosocial Predictors of Mortality Following Lung Transplantation..
16:271-277.
2016
-
Longitudinal studies of a B cell-derived signature of tolerance in renal transplant recipients..
15:2908-2920.
2015
-
Organ Allocation and Distribution: Lessons to Be Learned and Principles to Lead Us Forward..
15:2537-2538.
2015
-
Impact of CLAD Phenotype on Survival After Lung Retransplantation: A Multicenter Study..
15:2223-2230.
2015
-
Objective Estimates Improve Risk Stratification for Primary Graft Dysfunction after Lung Transplantation..
15:2188-2196.
2015
-
Studies Introducing Costimulation Blockade for Vascularized Composite Allografts in Nonhuman Primates..
15:2240-2249.
2015
-
Tacrolimus to Belatacept Conversion Following Hand Transplantation: A Case Report..
15:2250-2255.
2015
-
Apolipoprotein L1 gene variants in deceased organ donors are associated with renal allograft failure..
15:1615-1622.
2015
-
Tempering allorecognition to induce transplant tolerance with chemically modified apoptotic donor cells..
15:1475-1483.
2015
-
Dual islet transplantation modeling of the instant blood-mediated inflammatory reaction..
15:1241-1252.
2015
-
A pilot trial targeting the ICOS-ICOS-L pathway in nonhuman primate kidney transplantation..
15:984-992.
2015
-
National decline in donor heart utilization with regional variability: 1995-2010..
15:642-649.
2015
-
Neutralizing BAFF/APRIL with atacicept prevents early DSA formation and AMR development in T cell depletion induced nonhuman primate AMR model..
15:815-822.
2015
-
B cell activating factor (BAFF) and a proliferation inducing ligand (APRIL) mediate CD40-independent help by memory CD4 T cells..
15:346-357.
2015
-
Quantifying renal allograft loss following early antibody-mediated rejection..
15:489-498.
2015
-
Communication gaps associated with donor-derived infections..
15:259-264.
2015
-
Ebola virus disease: implications for solid organ transplantation..
15:5-6.
2015
-
Report from a forum on US heart allocation policy..
15:55-63.
2015
-
The future direction of the adult heart allocation system in the United States..
15:44-54.
2015
-
Novel once-daily extended-release tacrolimus (LCPT) versus twice-daily tacrolimus in de novo kidney transplants: one-year results of Phase III, double-blind, randomized trial..
14:2796-2806.
2014
-
Superiority of rapamycin over tacrolimus in preserving nonhuman primate Treg half-life and phenotype after adoptive transfer..
14:2691-2703.
2014
-
CD28 negative T cells: is their loss our gain?.
14:2460-2466.
2014
-
Impact of the lung allocation score on survival beyond 1 year..
14:2288-2294.
2014
-
Alemtuzumab induction in lung transplantation: time to move on?.
14:1721-1722.
2014
-
Enhancing human islet transplantation by localized release of trophic factors from PLG scaffolds..
14:1523-1532.
2014
-
Quantifying the risk of incompatible kidney transplantation: a multicenter study..
14:1573-1580.
2014
-
Epidemiology of invasive mold infections in lung transplant recipients..
14:1328-1333.
2014
-
Notes from the field: a cluster of lymphocytic choriomeningitis virus infections transmitted through organ transplantation-Iowa, 2013..
14:1459.
2014
-
Renal transplantation using belatacept without maintenance steroids or calcineurin inhibitors..
14:1142-1151.
2014
-
Antibody desensitization therapy in highly sensitized lung transplant candidates..
14:849-856.
2014
-
Bile acid aspiration associated with lung chemical profile linked to other biomarkers of injury after lung transplantation..
14:841-848.
2014
-
The role of donor-specific HLA alloantibodies in liver transplantation..
14:779-787.
2014
-
High CTLA-4 expression on Th17 cells results in increased sensitivity to CTLA-4 coinhibition and resistance to belatacept..
14:607-614.
2014
-
Vascular communications between donor and recipient tissues after successful full face transplantation..
14:711-719.
2014
-
Photodynamic therapy provides local control of cholangiocarcinoma in patients awaiting liver transplantation..
14:466-471.
2014
-
Preoperative plasma club (clara) cell secretory protein levels are associated with primary graft dysfunction after lung transplantation..
14:446-452.
2014
-
The allo- and viral-specific immunosuppressive effect of belatacept, but not tacrolimus, attenuates with progressive T cell maturation..
14:319-332.
2014
-
Costimulation blockade alters germinal center responses and prevents antibody-mediated rejection..
14:59-69.
2014
-
IL-15 expanded CD8+CD122+ cells: when do they suppress?.
14:7-8.
2014
-
Risk for transmission of Naegleria fowleri from solid organ transplantation..
14:163-171.
2014
-
Inhibition of αvβ6 promotes acute renal allograft rejection in nonhuman primates..
13:3085-3093.
2013
-
Role of pretransplant echocardiographic evaluation in predicting outcomes following liver transplantation..
13:2395-2401.
2013
-
Renal function at two years in liver transplant patients receiving everolimus: results of a randomized, multicenter study..
13:1734-1745.
2013
-
Role of T cell recruitment and chemokine-regulated intra-graft T cell motility patterns in corneal allograft rejection..
13:1461-1473.
2013
-
Chronic abdominal pain in a liver transplant recipient..
13:1364-1366.
2013
-
Class II alloantibody and mortality in simultaneous liver-kidney transplantation..
13:954-960.
2013
-
Colonization with small conidia Aspergillus species is associated with bronchiolitis obliterans syndrome: a two-center validation study..
13:919-927.
2013
-
Bronchoalveolar lavage as a tool to predict, diagnose and understand bronchiolitis obliterans syndrome..
13:552-561.
2013
-
Endemic fungal infections in solid organ transplantation..
13 Suppl 4:250-261.
2013
-
Posterior reversible encephalopathy syndrome independently associated with tacrolimus and sirolimus after multivisceral transplantation..
13:808-810.
2013
-
Pretransplant antithymocyte globulin has increased efficacy in controlling donor-reactive memory T cells in mice..
13:589-599.
2013
-
Belatacept and sirolimus prolong nonhuman primate islet allograft survival: adverse consequences of concomitant alefacept therapy..
13:312-319.
2013
-
Belatacept and sirolimus prolong nonhuman primate renal allograft survival without a requirement for memory T cell depletion..
13:320-328.
2013
-
Significance of and risk factors for the development of central airway stenosis after lung transplantation..
13:383-389.
2013
-
Functional status after lung transplantation in older adults in the post-allocation score era..
13:157-166.
2013
-
High-quality CMV-specific CD4+ memory is enriched in the lung allograft and is associated with mucosal viral control..
13:146-156.
2013
-
Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation..
13:100-110.
2013
-
Advantage of rapamycin over mycophenolate mofetil when used with tacrolimus for simultaneous pancreas kidney transplants: randomized, single-center trial at 10 years..
12:3363-3376.
2012
-
Beta-adrenergic receptor polymorphisms and cardiac graft function in potential organ donors..
12:3377-3386.
2012
-
Epithelial clara cell injury occurs in bronchiolitis obliterans syndrome after human lung transplantation..
12:3076-3084.
2012
-
Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial..
12:3008-3020.
2012
-
In the face of chronic aspiration, prolonged ischemic time exacerbates obliterative bronchiolitis in rat pulmonary allografts..
12:2930-2937.
2012
-
Intragraft CD11b(+) IDO(+) cells mediate cardiac allograft tolerance by ECDI-fixed donor splenocyte infusions..
12:2920-2929.
2012
-
Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort..
12:2997-3007.
2012
-
Platelet-derived CD154: ultrastructural localization and clinical correlation in organ transplantation..
12:3143-3151.
2012
-
Patterns of de novo allo B cells and antibody formation in chronic cardiac allograft rejection after alemtuzumab treatment..
12:2641-2651.
2012
-
Solid-organ transplantation in older adults: current status and future research..
12:2608-2622.
2012
-
Changes in neurocognitive functioning following lung transplantation..
12:2519-2525.
2012
-
Donor-specific CD8+ Foxp3+ T cells protect skin allografts and facilitate induction of conventional CD4+ Foxp3+ regulatory T cells..
12:2335-2347.
2012
-
Enhanced de novo alloantibody and antibody-mediated injury in rhesus macaques..
12:2395-2405.
2012
-
A novel monoclonal antibody to CD40 prolongs islet allograft survival..
12:2079-2087.
2012
-
Use of vascularized posterior rectus sheath allograft in pediatric multivisceral transplantation--report of two cases..
12:2242-2246.
2012
-
Alternative immunomodulatory strategies for xenotransplantation: CD40/154 pathway-sparing regimens promote xenograft survival..
12:1765-1775.
2012
-
CTLA4Ig prevents alloantibody formation following nonhuman primate islet transplantation using the CD40-specific antibody 3A8..
12:1918-1923.
2012
-
Evidence for kidney rejection after combined bone marrow and renal transplantation despite ongoing whole-blood chimerism in rhesus macaques..
12:1755-1764.
2012
-
Multiple hyperacute rejections in the absence of detectable complement activation in a patient with endothelial cell reactive antibody..
12:1643-1649.
2012
-
Regulatory T cells exhibit decreased proliferation but enhanced suppression after pulsing with sirolimus..
12:1441-1457.
2012
-
Is prevention the best treatment? CMV after lung transplantation..
12:539-544.
2012
-
Sirolimus conversion regimen versus continued calcineurin inhibitors in liver allograft recipients: a randomized trial..
12:694-705.
2012
-
Spirometrically significant acute rejection increases the risk for BOS and death after lung transplantation..
12:745-752.
2012
-
Clinical outcomes in kidney transplant recipients receiving long-term therapy with inhibitors of the mammalian target of rapamycin..
12:379-387.
2012
-
Cumulative exposure to gamma interferon-dependent chemokines CXCL9 and CXCL10 correlates with worse outcome after lung transplant..
12:438-446.
2012
-
CD40 blockade combines with CTLA4Ig and sirolimus to produce mixed chimerism in an MHC-defined rhesus macaque transplant model..
12:115-125.
2012
-
Integrin antagonists prevent costimulatory blockade-resistant transplant rejection by CD8(+) memory T cells..
12:69-80.
2012
-
Nondepleting anti-CD40-based therapy prolongs allograft survival in nonhuman primates..
12:126-135.
2012
-
Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function..
11:2593-2602.
2011
-
The first successful lower extremity transplantation: 6-year follow-up and implications for cortical plasticity..
11:2762-2767.
2011
-
Elevated plasma long pentraxin-3 levels and primary graft dysfunction after lung transplantation for idiopathic pulmonary fibrosis..
11:2517-2522.
2011
-
Regional variability in symptom-based MELD exceptions: a response to organ shortage?.
11:2353-2361.
2011
-
Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection..
11:2228-2234.
2011
-
Antibody-mediated rejection--an ounce of prevention is worth a pound of cure..
11:1131-1139.
2011
-
Donor-transmitted malignancies in organ transplantation: assessment of clinical risk..
11:1140-1147.
2011
-
CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates..
11:947-957.
2011
-
In pursuit of new experimental models of obliterative bronchiolitis..
11:882-883.
2011
-
Donor-directed MHC class I antibody is preferentially cleared from sensitized recipients of combined liver/kidney transplants..
11:841-847.
2011
-
Elevated plasma clara cell secretory protein concentration is associated with high-grade primary graft dysfunction..
11:561-567.
2011
-
Polyfunctional cytomegalovirus-specific immunity in lung transplant recipients receiving valganciclovir prophylaxis..
11:553-560.
2011
-
Sirolimus enhances the magnitude and quality of viral-specific CD8+ T-cell responses to vaccinia virus vaccination in rhesus macaques..
11:613-618.
2011
-
Implementation of vascularized composite allografts in the United States: recommendations from the ASTS VCA Ad Hoc Committee and the Executive Committee..
11:13-17.
2011
-
Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression..
11:22-33.
2011
-
L-selectin is dispensable for T regulatory cell function postallogeneic bone marrow transplantation..
10:2596-2603.
2010
-
Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation..
10:2082-2091.
2010
-
Fatal Apophysomyces elegans infection transmitted by deceased donor renal allografts..
10:2161-2167.
2010
-
Rapamycin-conditioned donor dendritic cells differentiate CD4CD25Foxp3 T cells in vitro with TGF-beta1 for islet transplantation..
10:1774-1784.
2010
-
Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry..
10:1621-1633.
2010
-
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients..
10:1268-1275.
2010
-
Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival..
10:1090-1107.
2010
-
Endemic fungal infections in solid organ transplant recipients..
9 Suppl 4:S199-S207.
2009
-
Impact of Medicare coverage on disparities in access to simultaneous pancreas and kidney transplantation..
9:2785-2791.
2009
-
Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation..
9:2435-2440.
2009
-
Impaired proinsulin processing is a characteristic of transplanted islets..
9:2119-2125.
2009
-
Long-term management of the liver transplant patient: recommendations for the primary care doctor..
9:1988-2003.
2009
-
An unwelcome guest: Aspergillus colonization in lung transplantation and its association with bronchiolitis obliterans syndrome..
9:1705-1706.
2009
-
BAFF is increased in renal transplant patients following treatment with alemtuzumab..
9:1835-1845.
2009
-
Perception versus reality?: Virtual crossmatch--how to overcome some of the technical and logistic limitations..
9:1886-1893.
2009
-
Factors associated with failure to list HIV-positive kidney transplant candidates..
9:1467-1471.
2009
-
Early and limited use of tacrolimus to avoid rejection in an alemtuzumab and sirolimus regimen for kidney transplantation: clinical results and immune monitoring..
9:1087-1098.
2009
-
Liver and intestine transplantation in the United States 1998-2007..
9:907-931.
2009
-
'Chimeric' grafts assembled from multiple allodisparate donors enjoy enhanced transplant survival..
9:473-482.
2009
-
Platelets influence vascularized organ transplants from start to finish..
9:14-22.
2009
-
Portal venous donor-specific transfusion in conjunction with sirolimus prolongs renal allograft survival in nonhuman primates..
9:124-131.
2009
-
Chronic kidney disease after hematopoietic cell transplantation: a systematic review..
8:2378-2390.
2008
-
What's next in the pipeline..
8:1972-1981.
2008
-
Successful bilateral lung transplantation for lymphangiomatosis..
8:1946-1950.
2008
-
Symptomatic pulmonary allograft Kaposi's sarcoma in two lung transplant recipients..
8:1951-1956.
2008
-
A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation..
8:1702-1710.
2008
-
Chronic aspiration of gastric fluid induces the development of obliterative bronchiolitis in rat lung transplants..
8:1614-1621.
2008
-
Factors affecting success of thymus transplantation for complete DiGeorge anomaly..
8:1729-1736.
2008
-
Unaltered graft survival and intragraft lymphocytes infiltration in the cardiac allograft of Cxcr3-/- mouse recipients..
8:1593-1603.
2008
-
Baseline 6-min walk distance predicts survival in lung transplant candidates..
8:1498-1505.
2008
-
Calcineurin inhibitor withdrawal after renal transplantation with alemtuzumab: clinical outcomes and effect on T-regulatory cells..
8:1529-1536.
2008
-
Rescue of a living donor with liver transplantation..
8:1557-1561.
2008
-
The Banff 2007 working classification of skin-containing composite tissue allograft pathology..
8:1396-1400.
2008
-
The association of state and national legislation with living kidney donation rates in the United States: a national study..
8:1451-1470.
2008
-
Pharmacokinetics of low and maintenance dose valganciclovir in kidney transplant recipients..
8:1297-1302.
2008
-
Survival after lung transplantation of cystic fibrosis patients infected with Burkholderia cepacia complex..
8:1025-1030.
2008
-
CD4+ CD25+ FOXP3+ regulatory T cells increase de novo in kidney transplant patients after immunodepletion with Campath-1H..
8:793-802.
2008
-
Liver and intestine transplantation in the United States, 1997-2006..
8:958-976.
2008
-
Allograft airway fibrosis in the pulmonary milieu: a disorder of tissue remodeling..
8:517-528.
2008
-
Long-term outcome of early steroid withdrawal after kidney transplantation in African American recipients monitored by surveillance biopsy..
8:574-585.
2008
-
Monocyte infiltration and kidney allograft dysfunction during acute rejection..
8:600-607.
2008
-
Ascites in hepatitis C liver transplant recipients frequently occurs in the absence of advanced fibrosis..
8:366-376.
2008
-
Surgical technique in transplantation: how much does it matter?.
15:2791-2792.
2015
-
The cornea has "the nerve" to encourage immune rejection..
15:1453-1454.
2015
-
The new OPTN kidney allocation policy: potential for inequitable access among highly sensitized patients..
15:284-285.
2015
-
Belatacept: is there BENEFIT for liver transplantation too?.
14:1717-1718.
2014
-
The cam-path forward..
13:9-10.
2013
-
Successful organ donation after long-term circulatory support with nonpulsatile mechanical support..
12:1962-1963.
2012
-
Vascularized composite allotransplantation research: the emerging field..
12:1062-1063.
2012
-
The risk and opportunity of homeostatic repopulation..
11:1349-1350.
2011
-
Miles to go…..
11:1119-1120.
2011
-
Guidance for liver transplant immunosuppression..
11:886-887.
2011
-
Seek and you will find: antibody and the liver..
11:424-425.
2011
-
Surgeons and research: talent, training, time, teachers and teams..
11:191-193.
2011
-
Now what?.
10:2385-2386.
2010
-
What should work, may not..
10:447-448.
2010
-
4D11: The Second Mouse?.
9:1701-1702.
2009
-
HLA-C and liver transplant outcomes: interpreting the facts..
9:1491-1492.
2009
-
AJT's response to the National Institutes of Health public access regulations..
8:1969.
2008
-
Finding the right job for the tool: alemtuzumab and its role in renal transplantation..
8:1363-1364.
2008
-
Immunity to varicella, measles, and mumps in patients evaluated for lung transplantation.
2021
-
Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody-associated arterial lesions.
2014
-
Coronary revascularization in lung transplant recipients with concomitant coronary artery disease.
2013
-
Summary of FDA workshop on ischemia reperfusion injury in kidney transplantation.
2013
-
Banff 2011 Meeting report: new concepts in antibody-mediated rejection.
2012
-
Summary of FDA antibody-mediated rejection workshop.
2011